One study showed that suppression of FGFR3 increased PD-L1 protein levels in FGFR3-expressing bladder cancer due to influencing its ubiquitination, leading to suppression of the anticancer activity of CD8+ T cells. This evidence concerns the gene CD8A and urinary bladder carcinoma.